New antidepressants: Use in high-risk patients

A. S. Hale, B. E. Leonard, P. E. Stokes, J. F. Greden, G. D. Tollefson, A. C. Altamura

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

This paper will review evidence on the safety and efficacy of new antidepressants in high-risk patients. Where available, data will be reviewed on the serotonin selective reuptake inhibitors (SSRIs), including fluoxetine, fluvoxamine, paroxetine, sertraline, and citalopram, and on the new reversible inhibitor of monoamine oxidase-A moclobemide.

Original languageEnglish
Pages (from-to)61-70
Number of pages10
JournalJournal of Clinical Psychiatry
Volume54
Issue number8 SUPPL.
Publication statusPublished - 1993

Fingerprint

Moclobemide
Fluvoxamine
Sertraline
Paroxetine
Citalopram
Monoamine Oxidase Inhibitors
Fluoxetine
Serotonin Uptake Inhibitors
Antidepressive Agents
Safety

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Clinical Psychology

Cite this

Hale, A. S., Leonard, B. E., Stokes, P. E., Greden, J. F., Tollefson, G. D., & Altamura, A. C. (1993). New antidepressants: Use in high-risk patients. Journal of Clinical Psychiatry, 54(8 SUPPL.), 61-70.

New antidepressants : Use in high-risk patients. / Hale, A. S.; Leonard, B. E.; Stokes, P. E.; Greden, J. F.; Tollefson, G. D.; Altamura, A. C.

In: Journal of Clinical Psychiatry, Vol. 54, No. 8 SUPPL., 1993, p. 61-70.

Research output: Contribution to journalArticle

Hale, AS, Leonard, BE, Stokes, PE, Greden, JF, Tollefson, GD & Altamura, AC 1993, 'New antidepressants: Use in high-risk patients', Journal of Clinical Psychiatry, vol. 54, no. 8 SUPPL., pp. 61-70.
Hale AS, Leonard BE, Stokes PE, Greden JF, Tollefson GD, Altamura AC. New antidepressants: Use in high-risk patients. Journal of Clinical Psychiatry. 1993;54(8 SUPPL.):61-70.
Hale, A. S. ; Leonard, B. E. ; Stokes, P. E. ; Greden, J. F. ; Tollefson, G. D. ; Altamura, A. C. / New antidepressants : Use in high-risk patients. In: Journal of Clinical Psychiatry. 1993 ; Vol. 54, No. 8 SUPPL. pp. 61-70.
@article{2df1e81ce7944551a495ec427869eb24,
title = "New antidepressants: Use in high-risk patients",
abstract = "This paper will review evidence on the safety and efficacy of new antidepressants in high-risk patients. Where available, data will be reviewed on the serotonin selective reuptake inhibitors (SSRIs), including fluoxetine, fluvoxamine, paroxetine, sertraline, and citalopram, and on the new reversible inhibitor of monoamine oxidase-A moclobemide.",
author = "Hale, {A. S.} and Leonard, {B. E.} and Stokes, {P. E.} and Greden, {J. F.} and Tollefson, {G. D.} and Altamura, {A. C.}",
year = "1993",
language = "English",
volume = "54",
pages = "61--70",
journal = "Journal of Clinical Psychiatry",
issn = "0160-6689",
publisher = "Physicians Postgraduate Press Inc.",
number = "8 SUPPL.",

}

TY - JOUR

T1 - New antidepressants

T2 - Use in high-risk patients

AU - Hale, A. S.

AU - Leonard, B. E.

AU - Stokes, P. E.

AU - Greden, J. F.

AU - Tollefson, G. D.

AU - Altamura, A. C.

PY - 1993

Y1 - 1993

N2 - This paper will review evidence on the safety and efficacy of new antidepressants in high-risk patients. Where available, data will be reviewed on the serotonin selective reuptake inhibitors (SSRIs), including fluoxetine, fluvoxamine, paroxetine, sertraline, and citalopram, and on the new reversible inhibitor of monoamine oxidase-A moclobemide.

AB - This paper will review evidence on the safety and efficacy of new antidepressants in high-risk patients. Where available, data will be reviewed on the serotonin selective reuptake inhibitors (SSRIs), including fluoxetine, fluvoxamine, paroxetine, sertraline, and citalopram, and on the new reversible inhibitor of monoamine oxidase-A moclobemide.

UR - http://www.scopus.com/inward/record.url?scp=0027292331&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027292331&partnerID=8YFLogxK

M3 - Article

C2 - 8253707

AN - SCOPUS:0027292331

VL - 54

SP - 61

EP - 70

JO - Journal of Clinical Psychiatry

JF - Journal of Clinical Psychiatry

SN - 0160-6689

IS - 8 SUPPL.

ER -